Palantir's Growth Prospects Shine Despite Privacy Concerns Around Controversial UK NHS Deal

Palantir reported strong Q2 earnings with consecutive quarters of GAAP profitability and raised guidance showing earnings momentum.

Palantir unveiled numerous AI partnerships and deals in recent weeks, showing strong demand for their platforms across industries.

Despite bright prospects, Palantir trades at reasonable valuations with forward P/E of 79 and P/S of 19, below 2021 levels.

Palantir's growth prospects boosted by potential S&P 500 inclusion which may come after Q3 2023 earnings.

Privacy concerns around controversial UK NHS deal presents some risks that Palantir must address through data privacy assurances.